Evidence map›Paper›PMID 30927027›Full record

ReviewDer Orthopade2019

[Arthroplasty of the TMT1 joint-a critical view].

M Jung, F Unglaub

Abstract readReview
PubMed Publisher
In one paragraph

Review in Der Orthopade, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. [Arthroplasty of the hand and wrist].Zeitschrift fur Rheumatologie · 2023
    Review
  2. [Thumb Arthritis - an update].Der Orthopade · 2022
    Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

M JungOrthopädische Chirurgie München, Steinerstr. 6, 81369, München, Deutschland. martin.jung@ocm-muenchen.de.
F UnglaubHandchirurgie, Vulpiusklinik, Bad Rappenau, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Resection suspension arthroplasty of the trapezium still represents the golden standard in treatment of CMC 1 arthritis. First reports about long-term results of a modern-design endoprosthesis of the CMC 1 joint promise a lower complication and revision rate. Thus, endoprosthesis of the CMC1 joint is becoming more attractive, especially because the rehabilitation and back-to-work times are much faster. While new anatomic prosthesis designs are coming onto the market, which theoretically are less susceptible to loosening and dislocation, they still have to prove their superiority in the clinical setting.

Indexed as

ArthroplastyJoint ProsthesisOsteoarthritisTrapezium BoneHumansThumbCMC 1 jointJoint replacementOsteoarthritisProsthesis looseningThumb

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.